Review article: Safe amounts of gluten for patients with wheat allergy or coeliac disease

C. Hischenhuber, R. Crevel, B. Jarry, M. Mäki, D. A. Moneret-Vautrin, A. Romano, R. Troncone, R. Ward

Research output: Contribution to journalArticlepeer-review

Abstract

For both wheat allergy and coeliac disease the dietary avoidance of wheat and other gluten-containing cereals is the only effective treatment. Estimation of the maximum tolerated amount of gluten for susceptible individuals would support effective management of their disease. Literature was reviewed to evaluate whether an upper limit for gluten content in food, which would be safe for sufferers from both diseases, could be identified. When setting gluten limits for coeliac disease sufferers, the overall potential daily intake should be considered, while for wheat allergy limits should be based on single servings. For coeliac disease sufferers this limit should lie between 10 and 100 mg daily intake. For wheat allergy, lowest eliciting doses for children lie in the lower milligram range, while for adults they are most significantly higher. Gliadins (part of the gluten proteins) not only trigger coeliac disease, but are also major allergens in wheat allergy. Therefore, measurement of gliadins with validated enzyme-linked immunosorbent assay methods provides an appropriate marker for assessing gluten and/or wheat protein contents in food. Available data suggest that a maximum gluten content for 'gluten-free' foods could be set, which protects both wheat allergy sufferers and coeliac patients.

Original languageEnglish
Pages (from-to)559-575
Number of pages17
JournalAlimentary Pharmacology and Therapeutics
Volume23
Issue number5
DOIs
Publication statusPublished - Mar 2006

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Review article: Safe amounts of gluten for patients with wheat allergy or coeliac disease'. Together they form a unique fingerprint.

Cite this